A high TRAP serum level at diagnosis is significantly associated with a better response to chemotherapy in ZA+ patients (and not in ZA− patients), suggesting that by decreasing OC function, patients defense to OS tumor evolvement significantly ameliorates when receiving chemotherapy in combination with ZA. The gene discussed is ACP5; the disease is neoplasm.